BERARDO, CLARISSA ANGELA IRIS
 Distribuzione geografica
Continente #
NA - Nord America 1.258
EU - Europa 676
AS - Asia 302
AF - Africa 5
SA - Sud America 1
Totale 2.242
Nazione #
US - Stati Uniti d'America 1.245
IE - Irlanda 393
CN - Cina 256
FI - Finlandia 64
DE - Germania 62
IT - Italia 61
BE - Belgio 25
SG - Singapore 25
CZ - Repubblica Ceca 24
SE - Svezia 22
CA - Canada 13
JP - Giappone 12
UA - Ucraina 10
GB - Regno Unito 9
IN - India 4
EG - Egitto 3
FR - Francia 2
IL - Israele 2
IR - Iran 2
AL - Albania 1
CY - Cipro 1
LV - Lettonia 1
MU - Mauritius 1
PE - Perù 1
RO - Romania 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 2.242
Città #
Chandler 427
Dublin 391
Boardman 72
Ashburn 65
Princeton 60
Lawrence 58
Helsinki 56
Medford 56
Shanghai 55
Beijing 53
Nanjing 40
Wilmington 35
Pavia 33
Ann Arbor 27
Jacksonville 27
Brussels 25
Brno 21
Munich 19
Singapore 18
Hebei 17
Nanchang 17
Toronto 13
Changsha 12
Tokyo 12
New York 11
Shenyang 10
Hangzhou 8
Jiaxing 8
Tianjin 8
Des Moines 7
Fairfield 7
Los Angeles 7
Seattle 6
Dallas 5
Houston 5
Raleigh 5
Redwood City 5
Berlin 4
Brescia 4
Cagliari 4
Dearborn 4
Falls Church 4
Laurel 4
Washington 4
Alexandria 3
Brdo 3
Chicago 3
Guangzhou 3
Andover 2
Bovisio Masciago 2
Cambridge 2
Caronno Pertusella 2
Fuzhou 2
Menlo Park 2
Milan 2
New Delhi 2
Ningbo 2
Orange 2
Paderno Dugnano 2
Rockville 2
Rome 2
Clearwater 1
Falkenstein 1
Frankfurt am Main 1
Giussano 1
Giza 1
Gunzenhausen 1
Haifa 1
Jerusalem 1
Kunming 1
Leawood 1
Lima 1
Littleton 1
London 1
Melegnano 1
Nicosia 1
Pune 1
Riga 1
San Francisco 1
Santa Clara 1
Southend 1
Tangshan 1
Timisoara 1
Tirana 1
Urbandale 1
Venegono Superiore 1
Verona 1
Verrua Po 1
Woodbridge 1
Wuhan 1
Xi'an 1
Totale 1.797
Nome #
Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile. 104
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 61
Autofluorescence discrimination of metabolic fingerprint in nutritional and genetic fatty liver models 59
Increase in transporter MATE-1 expression induced by obeticholic acid correlates with higher biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 57
Liver graft susceptibility during static cold storage and dynamic machine perfusion: DCD versus fatty livers 56
Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation 56
Changes in biliary levels of arginine and its methylated derivatives after hepatic ischaemia/reperfusion 55
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 55
Comparison between Lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma 54
Fluorescing fatty acids in rat fatty liver models 53
Liver plays a central role in asymmetric dimethylarginine-mediated organ injury 49
Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: Current issues and future perspectives in preclinical and clinical research 49
Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet 49
The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury 48
Oxygen tension-independent protection against hypoxic cell killing in rat liver by low sodium 47
Selective blockade of the metabotropic glutamate receptor mGluR5 protects mouse livers in in vitro and ex vivo models of ischemia reperfusion injury 47
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 45
Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV. 44
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update 44
Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract 43
Serum and hepatic autofluorescence as a real-time diagnostic tool for early cholestasis assessment 43
Fatty liver susceptibility to preservation injury using static cold storage versus dynamic machine perfusion 41
Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury 39
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 39
SAT-389-Obeticholic acid reduces matrix metalloproteinases activity via iNOS modulation in hepatic ischemia/reperfusion injury 38
The FXR agonist obeticholic acid decreases matrix metalloproteinase activity via RECK and TIMP modulation in hepatic ischemia/reperfusion injury 38
Analysis of Massaciuccoli Peat after Maturation in Sodium Chloride Water of Undulna Thermae 37
MPEP, a metabotropic Glutamate Receptor 5 (mGluR5) negative allosteric modulator, protects from hepatic ischemic injury both in vitro and ex vivo. 36
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis 36
Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats 36
Hepatic ischemia induces a time-dependent increase in SERPINB3 gene expression 36
MicroCT evaluation of low-density segmented volume in II, IV and VII-week MCD rats 34
P0006 : Hepatic ischemia/reperfusion induces changes in tissue and biliary levels of arginine and its methylated derivatives 34
Allosteric modulation of mGlu5 receptors by MPEP protects against hepatic cold ischemia and reperfusion injury 34
Obeticholic acid restores hepatic RECK content in a diet-induced ob/ob mouse model of NASH 33
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors 32
INOS-mediated decrease of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 32
Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression 31
Negative allosteric modulators of metabotropic glutamate receptor subtype 5 protect against hepatic ischemia/reperfusion injury 31
Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity 30
The Farnesoid-X-Receptor Agonist Obeticholic Acid Further Increases Biliary Excretion of Asymmetric Dimethylarginine during Hepatic Ischemia/Reperfusion Injury 30
Hepatic ischemic injury decreases using negative allosteric modulators of metabotropic glutamate receptor subtype 5 30
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 29
Fluorescence excitation properties of bilirubin in solution and in serum 29
Further increase in biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury by obeticholic acid, a farnesoid-X-receptor agonist 29
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats 29
Upregulation of MATE-1 transporter by obeticholic acid correlates with increased biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 29
NAD(P)H and Flavin Autofluorescence Correlation with ATP in Rat Livers with Different Metabolic Steady-State Conditions 28
Lobe-specific oxidative stress and matrix metalloproteinase activation in two animal models of non-alcoholic fatty liver disease (NAFLD) 28
Selective Blockade of Metabotropic Glutamate Receptor by MPEP Protects against Hepatic Cold Ischemia and Reperfusion Injury 28
Metabotropic glutamate receptor blockade reduces preservation damage in livers from donors after cardiac death 27
Oxidative stress, mitochondria damage and matrix metalloprotease activation in the pathogenesis of NAFLD 25
Machine perfusion at 20°C prevents ischemic injury and reduces hypoxia-inducible factor-1α expression during rat liver preservation 25
MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters 24
Spectrofluorometric analysis of autofluorescing components of crude serum from a rat liver model of ischemia and reperfusion 24
Changes in glutathione content in liver diseases: An update 24
MPEP administration reduces steatosis and inflammation in ob/ob mice 23
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 19
Innovative targets involved in the progression of NASH: Asymmetric-dymethylarginine (ADMA) and its cationic transporters 19
The Effect of Healthy Lifestyle Strategies on the Management of Insulin Resistance in Children and Adolescents with Obesity: A Narrative Review 17
Metalloproteinases activation involvement in the progression of liver injury from NAFLD to NASH 16
MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice 14
Use of Physical Activity and Exercise to Reduce Inflammation in Children and Adolescents with Obesity 13
Totale 2.344
Categoria #
all - tutte 12.743
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.743


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202068 0 0 0 0 0 3 3 2 0 24 34 2
2020/202179 2 2 1 2 0 15 17 17 11 6 5 1
2021/2022299 1 3 4 2 6 3 3 25 5 8 97 142
2022/20231.134 129 104 11 127 60 117 7 55 464 12 34 14
2023/2024364 66 43 15 18 34 69 41 23 0 15 10 30
2024/2025152 20 73 20 21 18 0 0 0 0 0 0 0
Totale 2.344